Drug treatment of convulsive disorders.
D000086:Acetazolamide / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D002648:Child; D003975:Diazepam / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D004832:Epilepsy, Absence / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005013:Ethosuximide / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D009207:Myoclonus / Q000188:drug therapy; D010080:Oxazoles / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy*; D014293:Trimethadione / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D010080:Oxazoles; D011760:Pyrrolidinones; D011324:Primidone; D005013:Ethosuximide; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D000086:Acetazolamide; D003975:Diazepam; D014293:Trimethadione; D010634:Phenobarbital